Success Stories: EB-1A Approved for Pharm Sci Scientist in California in the Field of Pharmaceutics
Client’s Testimonial:
Thanks a lot for your help! I already recommended your firm's name to all of my friends. [...] It was a pleasure working with your firm "best top-notch firm". You guys handled my case pretty nicely without any hiccup. I really liked your portal website for exchanging documents. You guys followed your committed timelines and answered all of my case-related and un-related questions.
On March 6th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Pharm Sci Scientist in the Field of Pharmaceutics (Approval Notice)
Position at the Time of Case Filing: Pharm Sci Scientist
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: March 6th, 2015
Processing Time: 5 Months, 23 Days
In this case, the client that we had the opportunity to work with was a Pharm Sci Scientist from India in the field of Pharmaceutics. His specialized research has focused on enhancing the bioavailability and deliverability of drug candidates through the application of novel formulation methodologies. His work had resulted in 11 peer-reviewed scientific articles, 1 book chapter, and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 467 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 33 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “The pharmaceutical industry often uses animal models such as rodents, dogs, and monkeys to predict the efficacy of nano-size formulations. These tests can often prove toxic or deadly. [Client’s] development allows performance prediction of nano-size formulations without the need for such models. The technique can make determinations based on aggregation and size.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutics, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 5 months and 23 days.